Dr Xiao is Director of the Immuno-Metabolic Computational Center at Massachusetts General Hospital and leads a Computational Genomics Group at the Stanford Genome Technology Center. His research focuses on developing computational and statistical methods to analyse complex molecular, clinical, and genetic data, with particular emphasis on immune and metabolic diseases. As Co-Director of the Ronald G. Tompkins Harvard ME/CFS Collaboration, he applies these approaches to study myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Dr Xiao’s work on the Severely Ill Patient Study (SIPS) has identified metabolic and immune abnormalities, rare genetic variants, and potential connections between ME/CFS and neuroimmune pathways, viral triggers, and hormonal signalling. His recent research uses network medicine to explore overlaps between ME/CFS, cognitive disorders, and long COVID, contributing to a better understanding of disease mechanisms and informing More information - https://researchers.mgh.harvard.edu/profile/13341354/Wenzhong-Xiao